UniTargetingResearch
UniTargetingResearch AS is a biotech company specializing in AI-driven genetic engineering and nucleic acid services. Their UTR® vector tools aim to overcome bottlenecks in protein expression, improving developability, scalability, and yield for various proteins like mAbs and monomers. They also offer nucleic acid services for quality extraction and assessment, with expertise in early detection and therapeutic profiling in oncology, including custom diagnostic assay development. The company has integrated its vector tools into global biopharmaceutical manufacturing platforms and previously offered the ColoAlert diagnostic test for colorectal cancer, which was sold to Mainz Biomed NV but remains a focus for further development. UniTargetingResearch AS was founded as a spin-off from universities in Norway, the UK, and Spain, leveraging significant IP and know-how in post-transcriptional regulation.
UniTargetingResearch
UniTargetingResearch AS is a biotech company specializing in AI-driven genetic engineering and nucleic acid services. Their UTR® vector tools aim to overcome bottlenecks in protein expression, improving developability, scalability, and yield for various proteins like mAbs and monomers. They also offer nucleic acid services for quality extraction and assessment, with expertise in early detection and therapeutic profiling in oncology, including custom diagnostic assay development. The company has integrated its vector tools into global biopharmaceutical manufacturing platforms and previously offered the ColoAlert diagnostic test for colorectal cancer, which was sold to Mainz Biomed NV but remains a focus for further development. UniTargetingResearch AS was founded as a spin-off from universities in Norway, the UK, and Spain, leveraging significant IP and know-how in post-transcriptional regulation.